Long-term safety of oral orforglipron in Japanese participants with type 2 diabetes (ACHIEVE-J): a multicentre, randomised, open-label, parallel-group phase 3 trial

The Lancet Diabetes & Endocrinology · Elsevier

Аннотация

Publication date: October 2026 Source: The Lancet Diabetes & Endocrinology, Volume 14, Issue 10 Author(s): Daisuke Yabe, Toshihiko Shiraiwa, Hiroyuki Ugai, Masakazu Takeuchi, Ryo Suzuki

Читать у издателя →

Похожие статьи